Reply to the letter regarding the article 'Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction'

被引:0
|
作者
Wood, Nathanael [1 ]
Witte, Klaus K. [2 ]
Bowen, T. Scott [1 ]
机构
[1] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, England
[2] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, England
关键词
D O I
10.1002/ejhf.3442
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Sodium-glucose co-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction
    Monzo, Luca
    Ferrari, Ilaria
    Cicogna, Francesco
    Tota, Claudia
    Cal, Leonardo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 341 : 56 - 59
  • [32] Sodium-glucose CO-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction
    Ferrari, Ilaria
    Cicogna, Francesco
    Tota, Claudia
    Calo, Leonardo
    Monzo, Luca
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [33] Effect of sodium-glucose cotransporter 2 inhibitors on left atrial remodeling and prognosis in patients with type 2 diabetes and heart failure with reduced ejection fraction
    Yu, Songqi
    Sun, Yuxi
    Wang, Ning
    Lv, Xin
    Si, Jinping
    Zhang, Xinxin
    Zhang, Yanli
    Liu, Ying
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (11) : 829 - 837
  • [34] Sodium-glucose CO-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction
    Ferrari, Ilaria
    Cicogna, Francesco
    Tota, Claudia
    Calo, Leonardo
    Monzo, Luca
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [35] Real-world use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry
    Stolfo, Davide
    Lund, Lars H.
    Benson, Lina
    Lindberg, Felix
    Ferrannini, Giulia
    Dahlstrom, Ulf
    Sinagra, Gianfranco
    Rosano, Giuseppe M. C.
    Savarese, Gianluigi
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (09) : 1648 - 1658
  • [36] Tolerability and safety barriers to sodium-glucose cotransporter 2 inhibitor initiation in heart failure with reduced ejection fraction
    Salah, Husam M.
    Fudim, Marat
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1633 - 1635
  • [37] Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure
    Shah, Kevin S.
    Fang, James C.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 109 - 120
  • [38] Sodium-Glucose Cotransporter 2 Inhibitors Reduce Residual Cardiovascular Risk in Heart Failure With Preserved Ejection Fraction
    Sakai, Takaaki
    Miura, Shinichiro
    CIRCULATION, 2019, 140
  • [39] Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction A protocol for meta-analysis
    Fukuta, Hidekatsu
    Hagiwara, Hiromi
    Kamiya, Takeshi
    MEDICINE, 2021, 100 (51) : E28448
  • [40] Obese or lean: Whom to prescribe sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction?
    Halavina, Kseniya
    Bartko, Philipp E.
    Nitsche, Christian
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (04) : 910 - 911